Application 020538
- Type
- NDA
- Sponsor
- NOVARTIS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ESTRADIOL | ESTRADIOL | Film, Extended Release; Transdermal | 0.0375MG/24HR | No | No |
| 002 | ESTRADIOL | ESTRADIOL | Film, Extended Release; Transdermal | 0.075MG/24HR | No | No |
| 003 | ESTRADIOL | ESTRADIOL | Film, Extended Release; Transdermal | 0.05MG/24HR | No | No |
| 004 | ESTRADIOL | ESTRADIOL | Film, Extended Release; Transdermal | 0.1MG/24HR | No | No |
| 005 | VIVELLE-DOT | ESTRADIOL | FILM, EXTENDED RELEASE;TRANSDERMAL | 0.0375MG/24HR | Yes | No |
| 006 | VIVELLE-DOT | ESTRADIOL | FILM, EXTENDED RELEASE;TRANSDERMAL | 0.05MG/24HR | Yes | No |
| 007 | VIVELLE-DOT | ESTRADIOL | FILM, EXTENDED RELEASE;TRANSDERMAL | 0.075MG/24HR | Yes | No |
| 008 | VIVELLE-DOT | ESTRADIOL | FILM, EXTENDED RELEASE;TRANSDERMAL | 0.1MG/24HR | Yes | Yes |
| 009 | VIVELLE-DOT | ESTRADIOL | FILM, EXTENDED RELEASE;TRANSDERMAL | 0.025MG/24HR | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020538-005 | VIVELLE-DOT | ESTRADIOL | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 |
| N020538-006 | VIVELLE-DOT | ESTRADIOL | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 |
| N020538-007 | VIVELLE-DOT | ESTRADIOL | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 |
| N020538-008 | VIVELLE-DOT | ESTRADIOL | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 |
| N020538-009 | VIVELLE-DOT | ESTRADIOL | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N020538-005 | AB1 |
| N020538-006 | AB1 |
| N020538-007 | AB1 |
| N020538-008 | AB1 |
| N020538-009 | AB1 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N020538-005 | VIVELLE-DOT | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N020538-006 | VIVELLE-DOT | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N020538-007 | VIVELLE-DOT | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N020538-008 | VIVELLE-DOT | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N020538-009 | VIVELLE-DOT | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-005 | VIVELLE-DOT | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-006 | VIVELLE-DOT | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-007 | VIVELLE-DOT | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-008 | VIVELLE-DOT | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-009 | VIVELLE-DOT | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-005 | VIVELLE-DOT | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-006 | VIVELLE-DOT | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-007 | VIVELLE-DOT | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-008 | VIVELLE-DOT | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-009 | VIVELLE-DOT | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-005 | VIVELLE-DOT | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-006 | VIVELLE-DOT | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-007 | VIVELLE-DOT | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-008 | VIVELLE-DOT | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-009 | VIVELLE-DOT | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-005 | VIVELLE-DOT | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-006 | VIVELLE-DOT | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-007 | VIVELLE-DOT | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-008 | VIVELLE-DOT | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-009 | VIVELLE-DOT | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-005 | VIVELLE-DOT | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-006 | VIVELLE-DOT | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-007 | VIVELLE-DOT | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-008 | VIVELLE-DOT | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-009 | VIVELLE-DOT | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-005 | VIVELLE-DOT | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-006 | VIVELLE-DOT | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-007 | VIVELLE-DOT | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-008 | VIVELLE-DOT | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-009 | VIVELLE-DOT | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-005 | VIVELLE-DOT | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-006 | VIVELLE-DOT | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-007 | VIVELLE-DOT | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-008 | VIVELLE-DOT | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-009 | VIVELLE-DOT | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 | b8a1b40f171c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N020538-005 | AB1 | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N020538-006 | AB1 | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N020538-007 | AB1 | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N020538-008 | AB1 | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N020538-009 | AB1 | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-005 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-006 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-007 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-008 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-009 | AB1 | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-005 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-006 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-007 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-008 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-009 | AB1 | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-005 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-006 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-007 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-008 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-009 | AB1 | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-005 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-006 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-007 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-008 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-009 | AB1 | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-005 | AB1 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-006 | AB1 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-007 | AB1 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-008 | AB1 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-009 | AB1 | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-005 | AB1 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-006 | AB1 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-007 | AB1 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-008 | AB1 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-009 | AB1 | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-005 | AB1 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-006 | AB1 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-007 | AB1 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-008 | AB1 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-009 | AB1 | 1 | b8a1b40f171c… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Estradiol | ESTRADIOL | Northwind Health Company, LLC | f6caf47a-1917-c493-e053-6394a90af63e | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | Estradiol ESTRADIOL |
| Estradiol | ESTRADIOL | Northwind Health Company, LLC | f6cb38ab-fdff-9c07-e053-6294a90ad59a | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | Estradiol ESTRADIOL |
| ESTRADIOL | ESTRADIOL | Northwind Health Company, LLC | f76aff99-f415-9045-e053-6294a90afd51 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL ESTRADIOL |
| Estradiol | ESTRADIOL | Teva Pharmaceuticals USA, Inc. | c94738ff-dece-4fb6-bb44-4f8832a45f38 | 2025-12-01 | Boxed warning, Warnings, Adverse reactions | Estradiol ESTRADIOL |
| Estradiol | ESTRADIOL | Alvogen Inc. | 0178a92c-62b1-d5cf-cf54-2c85af88a74a | 2025-11-25 | Boxed warning, Warnings, Adverse reactions | Estradiol ESTRADIOL |
| Estradiol | ESTRADIOL | NorthStar Rx LLC | 1c2cd11a-e010-20b2-e063-6294a90a52d5 | 2025-11-11 | Boxed warning, Warnings, Adverse reactions | Estradiol ESTRADIOL |
| Estradiol Vaginal | ESTRADIOL | Padagis Israel Pharmaceuticals Ltd | f76232ed-b109-43d1-bf2e-d41b6420c37d | 2025-10-31 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| Estradiol | ESTRADIOL | Bryant Ranch Prepack | ff3bcb07-f6fe-4582-948a-21dbf1e55f55 | 2025-10-28 | Boxed warning, Warnings, Adverse reactions | Estradiol ESTRADIOL |
| ESTRADIOL VAGINAL INSERTS | ESTRADIOL | Glenmark Pharmaceuticals Inc., USA | 86620f6c-fd02-40df-98d5-3048dcd92c37 | 2025-10-28 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| Estradiol Vaginal | ESTRADIOL | Bryant Ranch Prepack | f3806b5d-ebd6-43b4-adfa-a1fe86d80642 | 2025-10-23 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| ESTRADIOL VAGINAL INSERTS | ESTRADIOL | Aurobindo Pharma Limited | 6247e329-e20e-4ea5-9cc1-b593bd494577 | 2025-09-23 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| Estradiol | ESTRADIOL | NuCare Pharmaceuticals,Inc. | c8ac2e13-58d5-4e70-e053-2995a90aff04 | 2025-09-22 | Boxed warning, Warnings, Adverse reactions | Estradiol ESTRADIOL |
| ESTRADIOL VAGINAL INSERTS | ESTRADIOL | NorthStar Rx LLC | ad203bfd-28da-45a3-b9c0-7f886eb03634 | 2025-08-08 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| Estradiol | ESTRADIOL | A-S Medication Solutions | e962e36d-5d84-4b39-9bdf-e5f9a264b82a | 2025-07-24 | Boxed warning, Warnings, Adverse reactions | Estradiol ESTRADIOL |
| Estradiol | ESTRADIOL | A-S Medication Solutions | 13f9c41b-417c-45e4-9a59-baf774fca78d | 2025-07-24 | Boxed warning, Warnings, Adverse reactions | Estradiol ESTRADIOL |
| ESTRADIOL VAGINAL | ESTRADIOL | Encube Ethicals, Inc. | 1c61e837-4196-4b4d-9545-96b2d7c66f13 | 2025-07-17 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| Estradiol | ESTRADIOL | Mylan Pharmaceuticals Inc. | e7e6da3b-8485-1382-61c9-e9b369018b98 | 2025-06-23 | Boxed warning, Warnings, Adverse reactions | Estradiol ESTRADIOL |
| Estradiol | ESTRADIOL | Mylan Pharmaceuticals Inc. | f4efb0bf-b96f-4e20-a0f2-0806ab92b2d4 | 2025-06-23 | Boxed warning, Warnings, Adverse reactions | Estradiol ESTRADIOL |
| Estradiol | ESTRADIOL | Coupler LLC | 37c99e4d-fb0d-0e6e-e063-6394a90a69c8 | 2025-06-17 | Boxed warning, Warnings, Adverse reactions | Estradiol ESTRADIOL |
| Estradiol | ESTRADIOL | Mylan Pharmaceuticals Inc. | d28bec8f-762e-4f05-a20d-96a42970d6a7 | 2025-06-17 | Boxed warning, Warnings, Adverse reactions | Estradiol ESTRADIOL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0078-0343 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0343 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0343 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0343 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0343 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0344 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0344 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0344 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0344 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0344 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0345 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0345 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0345 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0345 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0345 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0346 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0346 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0346 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0346 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0346 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0365 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0365 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0365 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0365 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0365 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0781-7129 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7129 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7129 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7129 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7129 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7138 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7138 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7138 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7138 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7138 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7144 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7144 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7144 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7144 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7144 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7156 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7156 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7156 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7156 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7156 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7167 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7167 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7167 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7167 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7167 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 68071-3326 | Estradiol | estradiol | NuCare Pharmaceuticals,Inc. | NDA AUTHORIZED GENERIC | Current |
| 68071-3326 | Estradiol | estradiol | NuCare Pharmaceuticals,Inc. | NDA AUTHORIZED GENERIC | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 77569 | SUPPL | 2024-02-20 |
| 77546 | SUPPL | 2024-02-16 |
| 69008 | SUPPL | 2021-10-15 |
| 68886 | SUPPL | 2021-10-05 |
| 68885 | SUPPL | 2021-10-05 |
| 68874 | SUPPL | 2021-10-05 |
| 68873 | SUPPL | 2021-10-05 |
| 68541 | SUPPL | 2021-09-03 |
| 50287 | SUPPL | 2017-11-03 |
| 12696 | SUPPL | 2014-08-01 |
| 2687 | SUPPL | 2014-08-01 |
| 34795 | SUPPL | 2013-05-21 |
| 34794 | SUPPL | 2013-05-21 |
| 25134 | SUPPL | 2013-05-21 |
| 25133 | SUPPL | 2013-05-21 |
| 12695 | SUPPL | 2013-05-21 |
| 2686 | SUPPL | 2013-05-21 |
| 41418 | SUPPL | 2006-05-16 |
| 25132 | SUPPL | 2004-08-10 |
| 12694 | SUPPL | 2004-08-10 |
| 12693 | SUPPL | 2004-02-03 |
| 25131 | SUPPL | 2004-02-02 |
| 34793 | SUPPL | 2002-05-03 |
| 34792 | SUPPL | 2002-05-03 |
| 34791 | SUPPL | 2002-05-03 |
| 2685 | SUPPL | 2002-05-03 |
| 2684 | SUPPL | 2002-05-03 |
| 2683 | SUPPL | 2002-05-03 |
| 20708 | SUPPL | 1999-01-08 |
| 12692 | SUPPL | 1999-01-08 |
| 2682 | SUPPL | 1999-01-08 |